Amy Schacterle
Chief Operating Officer at SAGE THERAPEUTICS, INC.
Amy Schacterle active positions
Companies | Position | Start | End |
---|---|---|---|
SAGE THERAPEUTICS, INC. | Chief Operating Officer | 01/04/2020 | - |
Chief Tech/Sci/R&D Officer | 01/04/2020 | - | |
General Counsel | 13/02/2015 | 01/04/2020 |
Career history of Amy Schacterle
Former positions of Amy Schacterle
Companies | Position | Start | End |
---|---|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | General Counsel | 01/01/2004 | 01/01/2014 |
Training of Amy Schacterle
Rensselaer Polytechnic Institute | Undergraduate Degree |
University of Virginia | Doctorate Degree |
Statistics
International
United States | 5 |
Operational
General Counsel | 2 |
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SAGE THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Stock Market
- Insiders
- Amy Schacterle
- Experience